Want to join the conversation?
$ENDP 2Q15 Call: Our YTD results were driven by high single-digit underlying growth in our US branded pharmaceutical business & strong double digit underlying growth in our US generics business. While the international business was unfavorably impacted by stronger USD, the underlying performance of the business was in line with our expectations.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?